The fully linked HTML version of this article has now been published.
JCS ePress
online publication date 4 Jul 2006
doi: 10.1242/jcs.03036
Research Article
Disulfide bonds determine growth hormone receptor folding, dimerisation and ligand binding
Monique J.M. van den Eijnden,
Liza L. Lahaye,
and
Ger J. Strous*
* Author for correspondence (e-mail: strous{at}med.uu.nl)
The growth hormone receptor contains seven cysteine residues in its extracellular domain. The six in the growth hormone binding domain form disulfide bonds, and help the receptor to gain its correct three-dimensional structure. In this study we replaced the cysteine for serine and alanine residues and investigated their role in growth hormone receptor folding, dimerisation and signal transduction. Folding and growth hormone binding capacity of the wild-type growth hormone receptor require less than two minutes for completion. Although less efficient, all mutant receptors arrive at the cell surface as pre-formed dimers. Disulfide bond C38-C48 is important for efficient maturation. The middle disulfide-bond, C83-C94, is important for ligand binding. Removing disulfide bond C108-C122 has little effect without affecting signalling. When two or all disulfide bonds are changed, ligand binding and activation are blocked. Dimerisation is delayed when all disulfide bonds are destroyed.
This article has been cited by other articles:

|
 |

|
 |
 
P. Fang, R. Girgis, B. M. Little, K. L. Pratt, J. Guevara-Aguirre, V. Hwa, and R. G. Rosenfeld
Growth Hormone (GH) Insensitivity and Insulin-Like Growth Factor-I Deficiency in Inuit Subjects and an Ecuadorian Cohort: Functional Studies of Two Codon 180 GH Receptor Gene Mutations
J. Clin. Endocrinol. Metab.,
March 1, 2008;
93(3):
1030 - 1037.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Loesch, L. Deng, X. Wang, K. He, J. Jiang, and S. J. Frank
Endoplasmic Reticulum-Associated Degradation of Growth Hormone Receptor in Janus Kinase 2-Deficient Cells
Endocrinology,
December 1, 2007;
148(12):
5955 - 5965.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. J. van den Eijnden and G. J. Strous
Autocrine Growth Hormone: Effects on Growth Hormone Receptor Trafficking and Signaling
Mol. Endocrinol.,
November 1, 2007;
21(11):
2832 - 2846.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Fang, S. Riedl, S. Amselem, K. L. Pratt, B. M. Little, G. Haeusler, V. Hwa, H. Frisch, and R. G. Rosenfeld
Primary Growth Hormone (GH) Insensitivity and Insulin-Like Growth Factor Deficiency Caused by Novel Compound Heterozygous Mutations of the GH Receptor Gene: Genetic and Functional Studies of Simple and Compound Heterozygous States
J. Clin. Endocrinol. Metab.,
June 1, 2007;
92(6):
2223 - 2231.
[Abstract]
[Full Text]
[PDF]
|
 |
|
© The Company of Biologists Ltd 2006